Details for New Drug Application (NDA): 072934
✉ Email this page to a colleague
NDA 072934 describes FLUOCINONIDE, which is a drug marketed by Amneal, Cosette, Encube, Fougera Pharms Inc, Glenmark Pharms Ltd, Padagis Israel, Pai Holdings Pharm, Perrigo New York, Taro, Teva, Zydus Lifesciences, Alvogen, Padagis Us, Chartwell Rx, Fougera Pharms, Xiromed, Encube Ethicals, Macleods Pharms Ltd, Novel Labs Inc, Teva Pharms, and Zydus Pharms, and is included in forty-four NDAs. It is available from twenty-eight suppliers. Additional details are available on the FLUOCINONIDE profile page.
The generic ingredient in FLUOCINONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
The generic ingredient in FLUOCINONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 072934
| Tradename: | FLUOCINONIDE |
| Applicant: | Fougera Pharms Inc |
| Ingredient: | fluocinonide |
| Patents: | 0 |
Pharmacology for NDA: 072934
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 072934
Suppliers and Packaging for NDA: 072934
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FLUOCINONIDE | fluocinonide | SOLUTION;TOPICAL | 072934 | ANDA | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 0168-0134 | 0168-0134-60 | 1 BOTTLE in 1 CARTON (0168-0134-60) / 60 mL in 1 BOTTLE |
| FLUOCINONIDE | fluocinonide | SOLUTION;TOPICAL | 072934 | ANDA | Bryant Ranch Prepack | 72162-2146 | 72162-2146-6 | 1 BOTTLE in 1 CARTON (72162-2146-6) / 60 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Feb 27, 1995 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
